INTRODUCTIONHepatitis B Virus (HBV) is a double-stranded, enveloped DNA virus of the Hepadnaviridae family. It is transmitted parenterally or permucosal exposure to infected blood or other body fluids. Hepatitis B is a serious infectious disease of the liver which affects millions of people worldwide. Chronic viral hepatitis is a major global public health problem, an important cause of morbidity and mortality from sequelae which include chronic hepatitis, cirrhosis and primary liver cancer.1 India has intermediate endemicity of hepatitis B, with hepatitis B surface antigen (HBsAg) prevalence between 2% and 7%.2 HBV (Hepatitis B Virus) infection is an occupational hazard for health care workers and for public safety workers who have exposure to blood and blood products in the workplace and the risk of acquiring HBV infections depends on the frequency of percutaneous and ABSTRACT Background: HBV(Hepatitis B Virus) infection is an occupational hazard for health care workers and the risk of acquiring HBV infections depends on the frequency of percutaneous and permucosal exposure to blood or bloodcontaminated body fluids. Avoiding occupational blood exposure is primary preventive means for the transmission of HBV. However, the single most effective measure for the prevention of hepatitis B is active immunisation. Methods: A cross-sectional study was carried among 204 medical and nursing students in second year of their course using pre-designed questionnaire comprised of questions which included age, sex, qualification, awareness, occupational risk perception & vaccination against hepatitis B infection. Results: 69.12% of the respondents knew various modes of transmission of hepatitis B. More than half (56.86%) of the respondents knew that HBV infection causes liver cancer. 79.41% of the respondents knew the correct course of action after a needle stick injury. Only 61.27% of the respondents knew that blood soaked cotton and dressings are discarded in yellow coloured bags and that sharps and needles are disposed in white coloured bags. Only 36.46% of medical students & 57.41% of nursing students were completely vaccinated. Conclusion: Considering the long-term consequences of HBV infection, the health of the study population is at risk. Preventive strategies against the diseases, especially vaccination programmes, should be developed and taken aggressively to improve the vaccination coverage among the study population.
Background: Dengue fever and Dengue Haemorrhagic fever (DF/DHF) is an acute viral disease caused by Dengue virus. The infection is transmitted by the bite of an infected female mosquito- Aedes aegypti. The Dengue virus causes significant morbidity and mortality in many parts of the world, including India, where it was first isolated in Calcutta, West Bengal during 1945. This study was conducted to know the seroprevalence of Dengue virus in a tertiary care hospital, Hyderabad Methods: Blood for serological studies are carefully collected taking due universal precautions from suspected DF/DHF cases (a) as soon as possible after hospital admission or attendance. All the patients were screened for anti-Dengue IgG and IgM antibodies By Enzyme Immunoassay. The study period was 18 months from 2012. Results: From a total of 1327serum samples tested were screened for Dengue IgM and IgG among which 706(53.2%) were positive. 125(17.7%) were only IgM positive and 198(28.05%) of the tested samples showed only IgG positive. 383(54.25%) of the tested samples revealed positive for both IgM and IgG antibodies. Conclusion: Surveillance is prerequisite for monitoring the dengue situation in the area and should be carried out regularly for early detection of an impending outbreak and to initiate timely preventive and control measures. [Int J Res Med Sci 2013; 1(4.000): 448-450
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.